L26/P-820 Proteomic analysis of follicular fluid following platelet rich plasma (PRP) administration in diminished ovarian reserve (DOR) women: A before-after study with clinical validation
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Simopoulou und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does platelet rich plasma (PRP) administration in DOR women improve ovarian function and IVF cycle outcomes in DOR women? Summary answer Proteomic analysis indicates that PRP administration improves the ovarian microenvironment, activates folliculogenesis and enhances oocyte developmental competence in DOR women. What is known already The collapsed ovarian microenvironment observed in DOR women impacts IVF outcome. DOR women explore oocyte donation as a last resort in pursuing motherhood. The reproductive autonomy right for genetically related children serves as the incentive for novel approaches towards improving ovarian functionality. Intraovarian PRP constitutes an innovative approach targeting deterioration of ovarian physiology in DOR. Conflicting, scarce clinical data coupled by lack of molecular data on PRP’s regenerative potential, rendering PRP’s clinical application status experimental. To investigate whether PRP’s status could be shifted from experimental to clinical routine, requires contribution of robust translational and clinical data sourced by respective research. Study design, size, duration This before-after prospective study recruited 60 women, between 9/2024-9/2025, classified as DOR and fulfilling at least two out of the three following criteria: previous IVF attempts resulting to < 3 oocytes retrieved, and/or an abnormal ovarian reserve test of an antral follicle count (AFC)<5 follicles, and/or AMH levels<1.1ng/ml. Any other infertility etiology was excluded. Participants provided written informed consent before recruitment. Women were subjected to two ICSI cycles, one before and one after PRP administration. Participants/materials, setting, methods Follicular fluid from both before and after PRP administration was collected for proteomic analysis by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Acquired data were further analyzed employing Perseus. Hormonal levels and AFC were evaluated on day-3 of a Controlled Ovarian Stimulation (COS) cycle. Embryological data, including the number of oocytes retrieved, MII oocytes retrieved, 2PN zygotes, cleavage-stage embryos and blastocysts were recorded. Clinical data, namely clinical pregnancy with fetal heartbeat following PRP administration, was documented. Main results and the role of chance The average age of the participants was 43±3.5 years old. The proteomic analysis revealed a total of 2962 proteins expressed in the follicular fluid. Five proteins were observed to have significantly different expression levels before and after PRP administration. More specifically, HV5X1 and HV404, two immunoglobulin related proteins, were observed at significantly lower levels following PRP administration. On the other hand, Heterochromatin Protein 1-Binding Protein 3 (HP1BP3), Parathymosin and Prothymosin-alpha were observed at significantly higher levels following PRP administration. HP1BP3 maintains heterochromatin integrity, Parathymosin enhances cell cycle progression, while Prothymosin-alpha promotes estrogen receptor activity. Regarding hormonal levels, AMH and Estradiol on trigger day were at significantly higher levels following PRP administration (0.34±0.27 vs 0.51±0.32, p = 0.003; 241±166.9 vs 291±169, p = 0.04, respectively). Regarding IVF cycle outcomes, a higher number of oocytes retrieved (1.70±1.53 vs 2.23±1.81, p = 0.03), MII oocytes retrieved (1.03±1.19 vs 1.66±1.35, p = 0.02), 2PN zygotes (0.7±0.95 vs 1.1±0.9, p = 0.01), number of cleavage-stage embryos (0.63±0.89 vs 1.07±0.78, p = 0.001) and number of blastocysts (0.43±0.78 vs 0.68±0.76, p = 0.01) were observed following PRP administration. A total of 10 clinical pregnancies with fetal heartbeat were achieved post blastocyst embryo transfers following PRP administration. Limitations, reasons for caution The single-center nature of this study along with the fact that all participants were of the same ethnicity constitute main limitations of this study. Regarding the IVF outcomes, the small sample size is another reason for caution when interpreting the results of this study. Wider implications of the findings Proteomic analysis indicates that PRP administration activates folliculogenesis and enhances oocyte developmental competence. The enhanced hormonal levels and IVF cycle outcomes validate this data. Further transcriptomic analysis towards elucidating the mechanisms of PRP action in DOR women along with robust clinical data are required to render PRP application evidence based. Trial registration number No
Zitieren
APA
Simopoulou, M., Maziotis, E., Trypidi, A., Androutsopoulou, M., Papadogkonas, G., Samiotaki, M., Pantou, A., Sakkou, M., Grigoriadis, S., Agapitou, K., Nitsos, N., Pantos, K., & Sfakianoudis, K. (2026). L26/P-820 Proteomic analysis of follicular fluid following platelet rich plasma (PRP) administration in diminished ovarian reserve (DOR) women: A before-after study with clinical validation. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1147
Vancouver
Simopoulou M, Maziotis E, Trypidi A, Androutsopoulou M, Papadogkonas G, Samiotaki M, et al. L26/P-820 Proteomic analysis of follicular fluid following platelet rich plasma (PRP) administration in diminished ovarian reserve (DOR) women: A before-after study with clinical validation. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1147
BibTeX
@article{Simopoulou2026,
author = {Simopoulou, M. and Maziotis, E. and Trypidi, A. and Androutsopoulou, M. and Papadogkonas, G. and Samiotaki, M. and Pantou, A. and Sakkou, M. and Grigoriadis, S. and Agapitou, K. and Nitsos, N. and Pantos, K. and Sfakianoudis, K.},
title = {L26/P-820 Proteomic analysis of follicular fluid following platelet rich plasma (PRP) administration in diminished ovarian reserve (DOR) women: A before-after study with clinical validation},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1147}
}
EUVIMED